Telitacicept for systemic lupus erythematosus: protocol of a systematic review and meta-analysis
Introduction Systemic lupus erythematosus (SLE) is a chronic and complex multisystem autoimmune disease with high mortality. Telitacicept is a new strategy for the treatment of SLE, inhibiting the maturity, proliferation and differentiation of B cells, and thus, reduces disease activity. However, th...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMJ Publishing Group
2025-07-01
|
| Seria: | BMJ Open |
| Dostęp online: | https://bmjopen.bmj.com/content/15/7/e090646.full |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|